How can standard risk multiple myeloma (MM) patients be cured?
IMPACT: a UK clinical trials programme for hemonc patients post-transplant
How can MRD and disease be assessed in routine practice?
New endpoints in clinical trials to better serve patients
Elihu H. Estey
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?